Lupin has partnered Spain’s ERN to launch Luforbec for asthma and COPD, extending its respiratory franchise in Europe as the drugmaker continues to build momentum…

Punjab National Bank expects to raise $2.5-3 billion via FCNRB deposits after RBI measures, sees lower deposit costs, better NII and NIMs, and MSME advances…

Arvind Sanger, Managing Partner of Geosphere Capital Management discusses the risks facing global markets, including rising oil prices, Middle East tensions, AI-driven valuations, equity fundraising…

Speaking at the ICICI Securities Investor Conference 2026, B Prasanna, Head of Investment Banking & Institutional Equities at ICICI Securities, said the RBI had delivered…

As part of its IndiGo 2030 vision, the carrier is targeting annual capacity of 300 billion available seat kilometres (ASK) and plans to serve 200…

A rising US Dollar is generally negative for metals as they are globally priced in that currency and therefore a rising dollar means decreased purchasing…

Indian rupee opens sharply lower against US dollar as rising crude prices, Asian equity selloff and strong US jobs data weigh on sentiment.

For FY27 till May 31, the company recorded cumulative order inflows of ₹681.85 crore and executed orders worth ₹177.51 crore.

Five among the top 10 gainers on the Nifty 500 index are Pharma stocks. They include Pfizer (Up 4.6%), Anthem Biosciences (Up 2.5%), Syngene (Up…

Motilal Oswal purchased the stake on Friday at an average price of ₹619.07 per share, betting on one of the market’s best-performing stocks this year.